These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 37862345)
1. The macroeconomic burden of noncommunicable diseases and mental health conditions in South America. Ferranna M; Cadarette D; Chen S; Ghazi P; Ross F; Zucker L; Bloom DE PLoS One; 2023; 18(10):e0293144. PubMed ID: 37862345 [TBL] [Abstract][Full Text] [Related]
2. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study. Chen S; Kuhn M; Prettner K; Yu F; Yang T; Bärnighausen T; Bloom DE; Wang C Lancet Glob Health; 2023 Aug; 11(8):e1183-e1193. PubMed ID: 37474226 [TBL] [Abstract][Full Text] [Related]
3. The macroeconomic burden of noncommunicable diseases associated with air pollution in China. Chen S; Bloom DE PLoS One; 2019; 14(4):e0215663. PubMed ID: 30998763 [TBL] [Abstract][Full Text] [Related]
4. National Mental Health Survey of India, 2016 - Rationale, design and methods. Pradeep BS; Gururaj G; Varghese M; Benegal V; Rao GN; Sukumar GM; Amudhan S; Arvind B; Girimaji S; K T; P M; Vijayasagar KJ; Bhaskarapillai B; Thirthalli J; Loganathan S; Kumar N; Sudhir P; Sathyanarayana VA; Pathak K; Singh LK; Mehta RY; Ram D; T M S; Kokane A; R K LS; B S C; Sharma P; C R; P K D; Saha PK; Deuri SP; Giri AK; Kavishvar AB; Sinha VK; Thavody J; Chatterji R; Akoijam BS; Das S; Kashyap A; R V S; M S; S K S; Agarwal V; Misra R PLoS One; 2018; 13(10):e0205096. PubMed ID: 30359382 [TBL] [Abstract][Full Text] [Related]
5. The macroeconomic burden of noncommunicable diseases in the United States: Estimates and projections. Chen S; Kuhn M; Prettner K; Bloom DE PLoS One; 2018; 13(11):e0206702. PubMed ID: 30383802 [TBL] [Abstract][Full Text] [Related]
6. The economic burden of noncommunicable diseases and mental health conditions: results for Costa Rica, Jamaica, and Peru. Bloom DE; Chen S; McGovern ME Rev Panam Salud Publica; 2018; 42():e18. PubMed ID: 31093047 [TBL] [Abstract][Full Text] [Related]
7. Global economic consequences of selected surgical diseases: a modelling study. Alkire BC; Shrime MG; Dare AJ; Vincent JR; Meara JG Lancet Glob Health; 2015 Apr; 3 Suppl 2(Suppl 2):S21-7. PubMed ID: 25926317 [TBL] [Abstract][Full Text] [Related]
8. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050. Chen S; Cao Z; Prettner K; Kuhn M; Yang J; Jiao L; Wang Z; Li W; Geldsetzer P; Bärnighausen T; Bloom DE; Wang C JAMA Oncol; 2023 Apr; 9(4):465-472. PubMed ID: 36821107 [TBL] [Abstract][Full Text] [Related]
9. The global macroeconomic burden of road injuries: estimates and projections for 166 countries. Chen S; Kuhn M; Prettner K; Bloom DE Lancet Planet Health; 2019 Sep; 3(9):e390-e398. PubMed ID: 31538624 [TBL] [Abstract][Full Text] [Related]
10. The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories. Chen S; Cao Z; Nandi A; Counts N; Jiao L; Prettner K; Kuhn M; Seligman B; Tortorice D; Vigo D; Wang C; Bloom DE Lancet Glob Health; 2024 Sep; 12(9):e1534-e1543. PubMed ID: 39151988 [TBL] [Abstract][Full Text] [Related]
11. The Macroeconomic Impact of Increasing Investments in Malaria Control in 26 High Malaria Burden Countries: An Application of the Updated EPIC Model. Patouillard E; Han S; Lauer J; Barschkett M; Arcand JL Int J Health Policy Manag; 2023; 12():7132. PubMed ID: 38618809 [TBL] [Abstract][Full Text] [Related]
12. The Impact of Alzheimer's Disease on the Chinese Economy. Keogh-Brown MR; Jensen HT; Arrighi HM; Smith RD EBioMedicine; 2016 Feb; 4():184-90. PubMed ID: 26981556 [TBL] [Abstract][Full Text] [Related]
13. Macroeconomic costs of the unmet burden of surgical disease in Sierra Leone: a retrospective economic analysis. Grimes CE; Quaife M; Kamara TB; Lavy CBD; Leather AJM; Bolkan HA BMJ Open; 2018 Mar; 8(3):e017824. PubMed ID: 29540407 [TBL] [Abstract][Full Text] [Related]
14. Noncommunicable Diseases Attributable To Tobacco Use In China: Macroeconomic Burden And Tobacco Control Policies. Chen S; Kuhn M; Prettner K; Bloom DE Health Aff (Millwood); 2019 Nov; 38(11):1832-1839. PubMed ID: 31682483 [TBL] [Abstract][Full Text] [Related]
15. Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. Castaldelli-Maia JM; Wang YP; Brunoni AR; Faro A; Guimarães RA; Lucchetti G; Martorell M; Moreira RS; Pacheco-Barrios K; Rodriguez JAB; Roever L; Silva DAS; Tovani-Palone MR; Valdez PR; Zimmermann IR; Culbreth GT; Hay SI; Murray CJL; Bensenor IM Lancet Psychiatry; 2023 Feb; 10(2):85-97. PubMed ID: 36697127 [TBL] [Abstract][Full Text] [Related]
16. A review on Noncommunicable Diseases (NCDs) burden, its socio-economic impact and the strategies for prevention and control of NCDs in India. Kundu MK; Hazra S; Pal D; Bhattacharya M Indian J Public Health; 2018; 62(4):302-304. PubMed ID: 30539894 [TBL] [Abstract][Full Text] [Related]
17. The impact of seven major noncommunicable diseases on direct medical costs, absenteeism, and presenteeism in Gulf Cooperation Council countries. Finkelstein EA; Malkin JD; Baid D; Alqunaibet A; Mahdi K; Al-Thani MBH; Abdulla Bin Belaila B; Al Nawakhtha E; Alqahtani S; El-Saharty S; Herbst CH J Med Econ; 2021; 24(1):828-834. PubMed ID: 34138664 [TBL] [Abstract][Full Text] [Related]
18. The Economic Consequences Of Mortality Amenable To High-Quality Health Care In Low- And Middle-Income Countries. Alkire BC; Peters AW; Shrime MG; Meara JG Health Aff (Millwood); 2018 Jun; 37(6):988-996. PubMed ID: 29863936 [TBL] [Abstract][Full Text] [Related]
19. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Bommer C; Heesemann E; Sagalova V; Manne-Goehler J; Atun R; Bärnighausen T; Vollmer S Lancet Diabetes Endocrinol; 2017 Jun; 5(6):423-430. PubMed ID: 28456416 [TBL] [Abstract][Full Text] [Related]
20. Prevention and control of non-communicable diseases in iran: the case for Investment. Yousefi M; Dastan I; Alinezhad F; Ranjbar M; Hamelmann C; Ostovar A; Moghisi A; Mohammadi S; Mataria A; Hammerich A; Slama S; Pourghazian N; Hezaveh AM; Valizadeh B; Torabi P; Najmi M; Moradi M; Hodjatzadeh A; Keshvari-Shad F BMC Public Health; 2022 Jun; 22(1):1248. PubMed ID: 35739516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]